Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-XL inhibitor ABT-263 in KRAS-mutant colorectal cancers

Autor: Oh, Yumi, Jung, Hae Rim, Min, Seoyeon, Kang, Jinjoo, Jang, Dongjun, Shin, Seungjae, Kim, Jiwon, Lee, Sang Eun, Sung, Chang Ohk, Lee, Won-Suk, Lee, Charles, Jeong, Eui Man, Cho, Sung-Yup
Zdroj: In Cancer Letters 28 January 2021 497:123-136
Databáze: ScienceDirect